Studying synergism of methyl linked cyclohexyl thiophenes with triazole: Synthesis and their cdk5/p25 inhibition activity

European Journal of Medicinal Chemistry
2011.0

Abstract

A novel clubbed triazolyl thiophene series of cdk5/p25 inhibitors, potentially useful for the treatment of Alzheimer's disease, is disclosed. Evaluation of the SAR of substitution within these series has allowed the identification of a range of compounds which significantly reduce brain cdk5/p25 and thus have potential as possible treatments for Alzheimer's disease.

Knowledge Graph

Similar Paper

Studying synergism of methyl linked cyclohexyl thiophenes with triazole: Synthesis and their cdk5/p25 inhibition activity
European Journal of Medicinal Chemistry 2011.0
Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5/p25
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer’s disease
Medicinal Chemistry Research 2013.0
Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studies
Bioorganic & Medicinal Chemistry Letters 2011.0
Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: Synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis
Bioorganic & Medicinal Chemistry 2014.0
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships
European Journal of Medicinal Chemistry 2019.0
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases
Bioorganic & Medicinal Chemistry Letters 2004.0
Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling
Bioorganic & Medicinal Chemistry Letters 2013.0
5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents
Bioorganic & Medicinal Chemistry Letters 2000.0